Beyond the Gowers sign: measuring outcomes in Duchenne muscular dystrophy


  • Disclosures: PBK has received grant support as a site co-investigator from ISIS Pharmaceuticals, served as a site co-investigator for PTC Therapeutics, and serves on the editorial board of Pediatric Neurology.

Correspondence to: Peter B. Kang, MD, Department of Neurology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, 617-355-8235 (Phone), 617–730-0366 (Fax),

No abstract is available for this article.